BIO-CONVERT A/S: Financial statements 2022
CVR: 39842319
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIO-CONVERT A/S (CVR 39842319) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -15,230 and a net result of DKK -15,230 compared with DKK -24,197 the year before. Equity in the 2022 report amounted to DKK -62,155.
- Gross Profit
- DKK -15,230
- Profit/Loss
- DKK -15,230
- Equity
- DKK -62,155
- Total Assets
- DKK 32
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -15K | -15K | -62K | 0 |
| 2021 | - | -3K | -24K | -47K | - |
| 2020 | - | 143K | 109K | -23K | - |
Official annual report
Keep an eye on BIO-CONVERT A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 21, 2022, Christian Torben Hill-Madsen is registered as director of BIO-CONVERT A/S.
As of November 21, 2022, Nelli Carla Gotfredsen has stepped down as director of BIO-CONVERT A/S.
BIO-CONVERT A/S has published its annual report for 2021. Gross profit came to DKK -3,175, and the net result was DKK -24,197.
About BIO-CONVERT A/S
BIO-CONVERT A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named BIO-CONVERT ApS and Nordicare Danmark ApS. The management consists of Allan Traugott Wehnert. The board consists of Peter Severin Bach (chair), Christian Torben Hill-Madsen and Henrik Rouf. The company is owned by Nordicus Partners Corporation. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -621,998 and a net result of DKK -587,511. Equity in the 2026 report amounted to DKK 2,607,707.